Lataa...
The Role of Self-Nanoemulsifying Drug Delivery Systems of CDODA-Me in Sensitizing Erlotinib-Resistant Non–Small Cell Lung Cancer
We have investigated the effects of combination treatment involving ERL (erlotinib) with a glycyrrhetinic acid analog, CDODA-Me in overcoming ERL resistance, providing efforts to improve the oral bioavailability of this treatment using self-nanoemulsifying drug delivery systems (SNEDDS). A Qbd (qual...
Tallennettuna:
| Julkaisussa: | J Pharm Sci |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7790160/ https://ncbi.nlm.nih.gov/pubmed/31954111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xphs.2020.01.010 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|